, Dr E Lagier
, Amiens (Dr C. Roussel)
, Angers (Dr H. Le Guillou
, Avicenne (Dr C. Alloui)
, Besançon (Dr D. Bettinger
, Bicêtre (Dr C. Pallier)
,
,
, Caen (Professor A. Vabret
,
, Créteil (Dr M. Bouvier-Alias
, Dijon (Dr A. de Rougemont)
,
, Grenoble (Professor P. Morand, Dr A. Signori-Schmuck
, Bocket
, Limoges (Professor S. Rogez
,
,
,
, Montpellier (Dr B. Montes
, Nancy (Professor E. Schvoerer
, Nantes (Professor V. Ferre, Dr E. André-Garnier
, Nice (Dr J. Cottalorda
, Orléans (Dr J. Guinard, Dr A. Guiguon
, Dr G. Peytavin
,
, Dr V. Avettand-Fenoel
,
,
,
, Poitiers (Dr G. Giraudeau
,
, Rennes (Dr A. Maillard
, Rouen (Professor J.C. Plantier)
, Bourlet
,
, Suisse (Dr S. Yerly
, Toulon (Dr C. Poggi)
,
, Tours (Professor F. Barin, Dr A. Chaillon
, Versailles (Dr S. Marque-Juillet
, Dr S. Haïm-Boukobza
,
, ANRS Clinical Centres
,
, Amiens (Professor J.L. Schmit)
, Angers (Dr J. M. Chennebault
, Avicenne (Professor O. Bouchaud
, Bicêtre (Professor J.F. Delfraissy
, Bordeaux (Professor M. Dupon, Professor P. Morlat, Professor D. Neau)
, Brest (Professor S. Ansart, Dr S. Jaffuel
, Jacomet
,
, Dijon (Professor P. Chavanet; Professor L. Piroth
,
, Grenoble (Dr P. Leclercq)
, Cheret
, Limoges (Professor P. Weinbreck)
,
, Dr I. Ravaud
,
, Montpellier (Professor J. Reynes
,
, Nantes (Professor F. Raffi)
, Dr R. Landman, Professor Yazdanpanah
, Dr O. Launay
,
,
,
,
,
,
,
, Rennes (Professor C. Michelet)
,
,
, Suisse (Dr A Calmy
,
, Versailles (Dr A. Greder-Belan
,
Antiretroviral therapy and central nervous system HIV type 1 infection, J Infect Dis, vol.197, issue.3, pp.294-306, 2008. ,
Changing incidence of central nervous system diseases in the EuroSIDA cohort, Ann Neurol, vol.55, pp.320-328, 2004. ,
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection, J Acquir Immune Defic Syndr, vol.21, pp.271-277, 1999. ,
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment, BMC Infect Dis, vol.5, p.98, 2005. ,
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome, Ann Neurol, vol.42, pp.679-88, 1997. ,
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy, Clin Infect Dis, vol.50, pp.773-781, 2010. ,
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure, J Infect Dis, vol.194, pp.1686-96, 2006. ,
The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research, Antiviral Res, vol.82, pp.99-109, 2009. ,
Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting, J Infect, vol.65, pp.239-284, 2012. ,
Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid, AIDS, vol.14, pp.1949-54, 2000. ,
Emergence of raltegravirresistant HIV-1 in the central nervous system, Int J STD AIDS, vol.21, pp.840-841, 2010. ,
Raltegravir resistance in the cerebrospinal fluid, Infection, vol.41, pp.731-735, 2013. ,
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance, J Med Virol, vol.78, pp.153-60, 2006. ,
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update, PLoS One, vol.4, p.4724, 2009. ,
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIVinfected patients in France over a decade: 2001 -2011, J Antimicrob Chemother, vol.68, pp.2626-2657, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01101110
Prevalence of HIV-1 drug resistance in treated patients with viral load .50 copies/mL in 2009: a French nationwide study, J Antimicrob Chemother, vol.68, pp.1400-1405, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01984209
Differential genotypic evolution of HIV-1 quasispecies in cerebrospinal fluid and plasma: a systematic review, AIDS Rev, vol.15, pp.152-61, 2013. ,
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment, J Infect Dis, vol.202, pp.1819-1844, 2010. ,
HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis, AIDS, vol.24, pp.2412-2416, 2010. ,
Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients, AIDS, vol.16, pp.1867-76, 2002. ,
Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era, BMC Infect Dis, vol.7, p.147, 2007. ,
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort, AIDS, vol.25, pp.357-65, 2011. ,
Central nervous system complications in HIV disease: HIVassociated neurocognitive disorder, Top Antivir Med, vol.19, pp.137-179, 2011. ,